Real-Life Use of Filgotinib in Rheumatoid Arthritis: A Retrospective Cohort Study
Journal of Clinical Medicine · 27.11.2024 · 13 (23) · 7185
DOI: 10.3390/jcm13237185 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.11.2024. Verfasst von Vincenzo Raimondo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Clinic, ASP Crotone, 88836 Crotone, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alfasigma (Italy), Alfasigma S.p.A..
Abstract (Originalsprache)
Background
Janus kinase inhibitors (JAKis) are a novel class of drugs interfering with intracellular signaling of type I and type II cytokines, which play a crucial role in immune dysregulation associated with several chronic inflammatory diseases. Filgotinib (FIL), in particular, is the newest member of the JAKi class and exerts its therapeutic effects by selectively targeting and inhibiting the kinase activity of JAK1. While the efficacy of FIL in rheumatoid arthritis (RA) has been confirmed in clinical trials, real-world evidence may provide better insights into its effectiveness and safety in routine clinical practice.
Methods
We performed a multicenter, retrospective cohort study investigating the real-life effectiveness and safety of FIL in adult patients with RA. Demographic information, disease characteristics, prior treatment history, and comorbid conditions were retrieved from clinical records at baseline (M0) and after 3 (M3) and 6 months (M6) of treatment.
Results
A total of 82 patients (63 women) agreed to participate in the study, of whom 39 (47.6%) were older than 65 years. The average RA duration was 13 ± 9 years; 19 patients (23.1%) were current or former smokers, and 4 patients (4.9%) had a history of cardiovascular events. Most patients had previously received at least one biologic disease-modifying antirheumatic drug (range: 1–6+); in addition, 11 patients (13.4%) had been already exposed to another JAKi. During the follow-up, 7 patients discontinued treatment due to primary failure (n = 3) or adverse events (n = 4). Significant reductions in pain and number of tender and swollen joints were observed at M3 and M6. A relevant proportion of patients achieved DAS28-CRP remission at M3 and M6 (46.3% and 66.2%, respectively).
Conclusions
Our data provide additional insight into the effectiveness of filgotinib in a real-world setting, even among patients with difficult-to-treat RA and a high prevalence of cardiovascular risk factors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology Clinic, ASP Crotone, 88836 Crotone, Italy.
- Rheumatology Unit, Grande Ospedale Metropolitano, 89124 Reggio Calabria, Italy.
- Rheumatology Outpatient Clinic, ASP Crotone, Via Nazione Unite, 88900 Crotone, Italy.
- Rheumatology Clinic, ASP Cosenza, 87100 Cosenza, Italy.
- Rheumatology Outpatient Clinic, ASP Vibo Valentia-Tropea Hospital, 89861 Tropea, Italy.
- Internal Medicine Unit, Hospital of Paola-Cetraro, 87027 Paola, Italy.
ORCID-Profile: Vincenzo Raimondo, Domenico Olivo, Pietro Muto, Giuseppa Pagano Mariano, Jacopo Ciaffi
Förderung
- Alfasigma (Italy)
- Alfasigma S.p.A.
Zitieren
APA
Raimondo, V., Caminiti, M., Olivo, D., Gigliotti, P., L'Andolina, M., Muto, P., Pellegrini, R., Varcasia, G., Bruno, C., Massaro, L., Pagano Mariano, G., Luppino, J. M. E., Cirillo, M., Caira, V., Calabria, M., Ciaffi, J., Ferri, C., & Ursini, F. (2024). Real-Life Use of Filgotinib in Rheumatoid Arthritis: A Retrospective Cohort Study. Journal of Clinical Medicine, 13(23), 7185. https://doi.org/10.3390/jcm13237185
Vancouver
Raimondo V, Caminiti M, Olivo D, Gigliotti P, L'Andolina M, Muto P, et al. Real-Life Use of Filgotinib in Rheumatoid Arthritis: A Retrospective Cohort Study. Journal of Clinical Medicine. 2024;13(23):7185. doi:10.3390/jcm13237185
BibTeX
@article{Raimondo2024,
author = {Raimondo, Vincenzo and Caminiti, Maurizio and Olivo, Domenico and Gigliotti, Pietro and L'Andolina, Massimo and Muto, Pietro and Pellegrini, Roberta and Varcasia, Giuseppe and Bruno, Caterina and Massaro, Laura and Pagano Mariano, Giuseppa and Luppino, Jessica Maria Elisa and Cirillo, Mariateresa and Caira, Virginia and Calabria, Marilena and Ciaffi, Jacopo and Ferri, Clodoveo and Ursini, Francesco},
title = {Real-Life Use of Filgotinib in Rheumatoid Arthritis: A Retrospective Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {23},
pages = {7185},
doi = {10.3390/jcm13237185}
}
EUVIMED